NCT06457503 2026-03-02
TRANSPARENT
Coherus Oncology, Inc.
Phase 4 Recruiting
Clinical Trials
14 trialsNCT06820255 2025-02-11
SELECTIO-UC
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Phase 4 Recruiting
NCT06818773 2025-02-10
Inetetamab Plus Chemotherapy ± PD-1/PD-L1 in HER2+ Advanced Biliary Cancer
Eastern Hepatobiliary Surgery Hospital
Phase 4 Not yet recruiting
NCT05723991 2023-02-13
Study of Disitamab Vedotin Combined With Gemcitabine in Neoadjuvant Treatment of Urothelial Carcinoma
Tongji Hospital
Phase 4 Unknown
NCT05701332 2023-01-27
Effect of Intravesical B.C.G and Gemcitabine on Semen Quality and Testicular Volume
Assiut University
Phase 4 Unknown
NCT05035147 2021-09-21
Albumin-bound Paclitaxel Combined With Gemcitabine First-line Inoperable Pancreatic Cancer
Tianjin Medical University Cancer Institute and Hospital
Phase 4 Recruiting
NCT02812992 2021-08-10
GrantPax
AIO-Studien-gGmbH
Phase 4 Completed
NCT04040491 2020-05-12
PD-1 Antibody, Chidamide, Lenalidomide and Gemcitabine for Peripheral T-cell Lymphoma
Zhengzhou University
Phase 4 Unknown
NCT02996214 2020-02-13
LIPUSU
Nanjing Luye Sike Pharmaceutical Co., Ltd.
Phase 4 Unknown
NCT02316327 2016-10-05
Open-label Study in Patients With Metastatic NSLC Treated With Cisplatin, Gemcitabine and Bevacizumab
Fundacion Clinic per a la Recerca Biomédica
Phase 4 Completed
NCT00642733 2016-08-24
A Study of First Line Treatment With Tarceva (Erlotinib) in Combination With Gemcitabine in Patients With Locally Advanced Unresectable or Metastatic Pancreatic Cancer
Hoffmann-La Roche
Phase 4 Terminated
NCT00352859 2014-12-30
Phase IV Randomization to On-Going Treatment to Evaluate Sustained Sorafenib
Bayer
Phase 4 Terminated
NCT02194556 2014-07-18
Sequential and Maintenance Icotinib Plus Chemotherapy Versus Icotinib Maintenance After Chemotherapy in Advanced NSCLC
Betta Pharmaceuticals Co., Ltd.
Phase 4 Unknown
NCT01336192 2011-04-15
MAGICAL
Tongji University
Phase 4 Unknown